ArticleOncotarget2018

Inhibition of mTOR downregulates expression of DNA repair proteins and is highly efficient against BRCA2-mutated breast cancer in combination to PARP inhibition.

Rania El Botty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.